Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Not applicableUnknownNCT04507815
What this trial is testing

TDCS and Cognitive Training for Mild Cognitive Impairment and Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Minneapolis Veterans Affairs Medical Center 50
Not applicableUnknownNCT06158789
What this trial is testing

Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Kyung Won Chang 6
Post-approval studies (Phase 4)Ended earlyNCT00649220
What this trial is testing

Memantine and Antipsychotics Use

Who this might be right for
Alzheimer's Disease
Merz Pharmaceuticals GmbH 19
Large-scale testing (Phase 3)Study completedNCT02442778
What this trial is testing

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Participants With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 522
Early research (Phase 1)Study completedNCT00203320
What this trial is testing

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Tobinick, Edward Lewis, M.D. 30
Large-scale testing (Phase 3)Ended earlyNCT00679627
What this trial is testing

Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 2,051
Testing effectiveness (Phase 2)Study completedNCT02549196
What this trial is testing

A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type

Who this might be right for
Dementia of Alzheimer's Type
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 28
Not applicableStudy completedNCT00297362
What this trial is testing

The Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Cilag Pharmaceutica S.A.C.I., Greece 344
Large-scale testing (Phase 3)Study completedNCT01404169
What this trial is testing

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
Eisai Limited 260
Testing effectiveness (Phase 2)Study completedNCT06292351
What this trial is testing

DMB-I in the Treatment of Alzheimer Type Dementia

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
Bigespas LTD 133
Not applicableActive Not RecruitingNCT03556280
What this trial is testing

Multi-Center Study of Sensory Stimulation to Improve Brain Function

Who this might be right for
Alzheimer DiseaseCognitive ImpairmentMild Cognitive Impairment+7 more
Cognito Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Large-scale testing (Phase 3)Study completedNCT00338117
What this trial is testing

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 554
Large-scale testing (Phase 3)Ended earlyNCT00857233
What this trial is testing

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 297
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Early research (Phase 1)Study completedNCT04749563
What this trial is testing

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia of Alzheimer Type
IGC Pharma, LLC 12
Not applicableUnknownNCT04526262
What this trial is testing

Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Yonsei University 6
Post-approval studies (Phase 4)Study completedNCT00334906
What this trial is testing

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

Who this might be right for
Alzheimer's Disease
Forest Laboratories 75
Not applicableStudy completedNCT01972204
What this trial is testing

Intensive Instruction on the Use of Aricept

Who this might be right for
Alzheimer's Type Dementia
Mirai Iryo Research Center, Inc. 125
Next Page